3 stories mentioning SHA:688806Updated 28d ago
Every FINWIRES story that references SHA:688806, newest first.
Zhuhai Trinomab Pharmaceutical (SHA:688806) shares opened at 50.15 yuan on their first day of trading on the Shanghai bourse.This marked a 247% jump from the initial public offering price of 14.46 yuan per share.
Zhuhai Trinomab Pharmaceutical (SHA:688806) is seeking to raise 998.9 million yuan via the issue of 69.1 million shares at 14.46 yuan apiece, according to a Thursday filing with the Shanghai bourse.The expected offering date is July 10, with proceeds to be used for new drug research and development, antibody manufacturing expansion, and for working capital.Huatai United Securities serves as lead underwriter.
Zhuhai Trinomab Pharmaceutical (SHA:688806) filed a prospectus for the initial public offering of 69.1 million shares on the Shanghai bourse's STAR Market.Proceeds will be used for new drug research and development, antibody manufacturing expansion and for working capital, according to the Thursday prospectus.The expected offering date is July 10.Huatai United Securities serves as lead underwriter.
